Megan Farris
Megan Farris

As a Research Manager, Megan supports Real-World Evidence, Evidence Generation, and Health Technology Assessment projects. She uses her experience across a breadth of research methodologies to develop materials for both public and private sector organizations. Megan’s skills include data analysis, biostatistics, epidemiological study design, literature review, and medical writing.

Before joining Medlior, Megan gained two years of experience as a Research Associate in the Department of Cancer Epidemiology and Prevention Research at Alberta Health Services.

Megan holds an MSc in Epidemiology from the University of Calgary.

Recent Medlior publications by Megan

  • C.Hawes, S. Harris, F. Mubarack, D. Hinds, T. Cowling, C. Waters‐Banker, M. Farris, A. About‐Setta. Comparative effectiveness and safety, and health‐related quality of life of haemophilia A treatments: A systematic review. (2020), Abstracts. Haemophilia, 26: 27-181. https://onlinelibrary.wiley.com/doi/10.1111/hae.13911

    https://www.medlior.com/insights/haemophilia-a-slr-project/

  • Chen G, Sharif B, Farris MS, Cowling T, Pinto L, Rogoza R, Fairbarin M, Anderson T. Healthcare resource utilization and associated costs among patients with atherosclerotic cardiovascular diseases in Alberta, Canada. Canadian Journal of Cardiology 2020;30(10): S20. https://www.onlinecjc.ca/article/S0828-282X(20)30682-6/fulltext
  • Chen G, Sharif B, Gerber B, Farris MS, Cowling T, Cabalteja C, Wu JW, Maturi B, Klein-Panneton K, Mah JK. A population-based study examining the epidemiologic burden, healthcare resource utilization and costs of spinal muscular atrophy in Alberta, Canada. Presented at the 25th International Annual Congress of the World Muscle Society, October 1, 2020; Virtual Congress.
  • Chen G, Sharif B, Gerber B, Farris MS, Cowling T, Cabalteja C, Wu JW, Maturi B, Klein-Panneton K, Mah JK. A population-based study examining the epidemiologic burden, healthcare resource utilization and costs of spinal muscular atrophy in Alberta, Canada. Neuromuscular Disorders 2020; 30(Supplement 1): S101. https://www.nmd-journal.com/article/S0960-8966(20)30383-7/pdf
  • Chen G, Farris MS, Cowling T, Colgan SM, Xiang P, Pericleous L, Rogoza RM, Tai M, Anderson T. Treatment and Low-density Lipoprotein Cholesterol management in patients diagnosed with clinical Atherosclerotic Cardiovascular Disease in Alberta. Canadian Journal of Cardiology 2019;35(7):884-891.
  • Nakagawa K, Matsumura K, Scory T, Farris MS, Larkin-Kaiser KA, Kikkawa H, Ivanova JI, Wilner KD. Indirect analysis of first-line therapy for advanced non-small-cell lung cancer with activating mutations in the Japanese population. Future Oncol; Published online 23 Sep 2020.
    https://www.futuremedicine.com/doi/10.2217/FON-2020-0651
  • Farris MS, Larkin-Kaiser KA, Scory T, Boyne D, Wilner KD, Pastel M, Cappelleri JC, Ivanova JI. Network meta-analysis of first-line therapy for advanced EGFR mutation positive non-small-cell lung cancer: updated overall survival. Future Oncol; Published online 1 Sep 2020.
  • Chen G, Farris MS, Cowling T, Colgan S, Xiang P, Pericleous L, Rogoza RM, Tai MH, Anderson TJ. Treatment and Low-density Lipoprotein Cholesterol management in patients diagnosed with clinical Atherosclerotic Cardiovascular Disease in Alberta. Can J Cardiol. 2019; 35:7:884-894
  • Scory T, Chen G, Farris MS, Shih YH, Pinto L, Cowling T. Lipid-lowering therapy patterns and low-density lipoprotein-cholesterol management among patients with acute myocardial infarction in Alberta, Canada. American College of Cardiology (ACC).20/World Congress of Cardiology (WCC) Virtual; March-June 2020; Virtual.
  • Chen G, Farris MS, Cowling T, Tai M, Pinto L, Colgan S, Rogoza RM, Anderson TJ. Low-density Lipoprotein Cholesterol Management in Patients with Atherosclerotic Cardiovascular Diseases and Pre-existing Diabetes in Alberta, Canada. American Diabetes Association (ADA) 79th Scientific Sessions 2019; June 8, 2019; San Francisco, California
    https://www.medlior.com/wp-content/uploads/2020/02/ADA-Alberta-ASCVD-RWE-Poster_2019-5-1-FINAL-Read-Only.pdf
    https://www.medlior.com/low-density-lipoprotein-cholesterol-management-in-patients-with-atherosclerotic-cardiovascular-diseases-and-pre-existing-diabetes/
  • Jimenez-Zepeda VH, Chen G, Cowling T, Shaw E, Farris MS, Liu FF, Tay J. Multiple Myeloma Treatment Landscape from 2011 to 2017 in Alberta, Canada: Results from the Population-Based “Identifying Outcomes in Real-World Multiple Myeloma” (INFORMM) Study. Presented at the 24th Congress of the European Hematology Association (EHA); June 13–16, 2019; Amsterdam, Netherlands.
    https://www.medlior.com/wp-content/uploads/2020/02/Zepeda-et-al-EHA-2019_Jun-5.pdf
    https://www.medlior.com/eha-2019-identifying-outcomes-in-real-world-multiple-myeloma/
  • Tay J, Chen G, Cowling T, Shaw E, Farris MS, Liu FF, Jimenez-Zepeda VH. Early mortality following diagnosis of multiple myeloma from 2011 to 2016 in Alberta, Canada: Initial results from the population-based Identifying Outcomes in Real-World Multiple Myeloma (INFORMM) study. Accepted for the 2019 ASCO Annual Meeting. J Clin Oncol 37, 2019 (suppl; abstr e19509)
    https://meetinglibrary.asco.org/record/172181/abstract
    https://www.medlior.com/asco-2019-identifying-outcomes-in-real-world-multiple-myeloma/
  • Chen G, Farris MS, Cowling T, Colgan S, Xiang P, Pericleous L, Rogoza RM, Tai MH, Anderson TJ. Treatment and Low-density Lipoprotein Cholesterol management in patients diagnosed with clinical Atherosclerotic Cardiovascular Disease in Alberta. Can J Cardiol. 2019; 35:7:884-894
    https://www.onlinecjc.ca/article/S0828-282X(19)30269-7/fulltext
  • Chen G, Farris MS, Cowling T, Colgan S, Xiang P, Pericleous L, Rogoza RM, Anderson TJ. Atherosclerotic Cardiovascular Diseases and Low-Density Lipoprotein Cholesterol Management in Alberta, Canada. Presented at the American Heart Association Scientific Sessions, November 2018; Chicago, USA.
  • Farris M, White K, Liu FF, Cowling T. A Rapid Literature Review of Real-World Evidence in Multiple Myeloma: Patient Characteristics and Health Outcomes. Presented at ISPOR Europe 2018, November 2018; Barcelona, Spain.
  • Chen G, Farris M and Cowling T. Methodological issues for measuring pharmacotherapy treatment and its calibration with patient outcomes using real-world data. International Journal Population Data Science. 2018; 3:3: 170.